Plasma Cholesterol Concentration and Mortality: The Whitehall Study

JAMA: The Journal of the American Medical Association

Volumn 267, Issue 1, 1992, Pages 70-76

  Smith, George Davey ^a   Shipley, Martin J ^a   Marmot, Michael G ^a   Rose, Geoffrey ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; SOCIAL STATUS;

ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL; COHORT STUDIES; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; MORTALITY; NEOPLASMS; POISSON DISTRIBUTION; RESPIRATORY TRACT DISEASES;

EID: 0026526879     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03480010078028     Document Type: Article

References (72)

1. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis. 1980;33:311-322.
2. Salmond CE, Beaglehole R, Prior IAM. Are low cholesterol values associated with excess mortality? BMJ. 1985;290:422-424.
3. Cambien F, Ducimetiere P, Richard J. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol. 1980;112:388-394.
4. Stemmermann GN, Chyou P-H, Kagan A, Nomura AMY, Yano K. Serum cholesterol and mortality among Japanese-American men: the Honolulu (Hawaii) Heart Program. Arch Intern Med. 1991;151:969-972.
5. Kozarevic DJ, McGee D, Vojvodic N, et al. Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. Am J Epidemiol. 1981;114:21-28.
6. Peterson B, Trell E. Premature mortality in middle-aged men: serum cholesterol as risk factor. Klin Wochenschr. 1983;63:795-801.
7. Garcia-Palmiere MR, Sorlie PD, Costas R, Havlik RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol. 1981;114:29-40.
8. Hiatt RA, Fireman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis. 1986;39:861-870.
9. Wallace RB, Rost C, Burmeister LF, Pomrehn PR. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst. 1982;68:915-918.
10. Kagan A, McGee DL, Yano K, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese-American population. Am J Epidemiol. 1981;114:11-20.
11. Tornberg SA, Holm L-E, Carstensen JM, Eklund GA. Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst. 1989;81:1917-1921.
12. Schatzkin A, Hoover RN, Taylor PR, et al. Serum cholesterol and cancer in the NHANES-I epidemiological follow-up study. Lancet. 1987;2:298-301.
13. Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley Survey. BMJ. 1989;298:920-924.
14. Williams RR, Sorlie PD, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA. 1981;245:247-252.
15. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality: findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. In press.
16. Morris DL, Borhani NO, Fitzsimons E, et al. Serum cholesterol concentration and cancer in the Hypertension Detection and Follow-up Program. Cancer. 1983;52:1754-1759.
17. Cowan LD, O’Connell DL, Criqui MH, Barrett-Connor E, Bush TL, Wallace RB. Cancer mortality and lipid and lipoprotein levels: the Lipid Research Clinics Program Mortality Follow-up Study. Am J Epidemiol. 1990;131:468-482.
18. Bottiger LE, Carlson LA. Risk factors for death for males and females: a study of the death pattern in the Stockholm Prospective Study. Acta Med Scand. 1982;211:437-442.
19. Salonen JT. Risk of cancer and death in relation to serum cholesterol. Am J Epidemiol. 1982;116:622-630.
20. Westlund K, Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol. Scand J Clin Lab Invest. 1972;30(suppl 127):3-24.
21. Dyer AR, Stamler J, Paul O, et al. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. J Chronic Dis. 1981;34:249-260.
22. Wingard DL, Criqui MH, Holdbook MJ, Barrett-Connor E. Plasma cholesterol and cancer morbidity and mortality in an adult community. J Chronic Dis. 1984;37:401-406.
23. Kromhout D, Bosschieter EB, Drijver M, Coulander C. Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer: the Zutphen Study. Arch Intern Med. 1988;148:1051-1055.
24. Shaper AG, Phillips AN, Pocock SJ. Plasma cholesterol, coronary heart disease and cancer. BMJ. 1989;298:1381.
25. Wald NJ, Thompson SG, Law MR, Densem JW, Bailey A. Serum cholesterol and subsequent risk of cancer: results from the BUPA Study. Br J Cancer. 1989;59:936-938.
26. Farchi G, Menotti A, Conti S. Coronary disease and survival probability from coronary and other causes of death. Am J Epidemiol. 1987;126:400-408.
27. Yaari S, Even-Zohar S, Goldbourt U, Neufeld HN. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men. Lancet. 1981;1:1011-1015.
28. Persson B, Johansson BW. The Kockum Study: twenty-two years follow-up. Acta Med Scand. 1984;216:485-493.
29. Rose G, Shipley M. Plasma lipids and mortality: a source of error. Lancet. 1980;1:523-526.
30. International Collaborative Group. Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. JAMA. 1982;248:2853-2859.
31. Gerhardsson M, Rosenqvist U, Ahlbom A, Carlson LA. Serum cholesterol and cancer: a retrospective case-control study. Int J Epidemiol. 1986;15:155-159.
32. Winawer SJ, Flehinger BJ, Buchalter J, Herbert E, Shike M. Declining serum cholesterol levels prior to diagnosis of colon cancer. JAMA. 1990;263:2083-2085.
33. Reid DD, Brett GZ, Hamilton PJS, Jarrett RJ, Keen H, Rose G. Cardiorespiratory disease and diabetes among middle-aged male civil servants. Lancet. 1974;1:469-473.
34. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 1988;41:251-260.
35. Cloey T, Bachorik PS, Becker D, Finney C, Lowry D, Sigmund W. Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA. 1990;263:2788-2789.
36. Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10-year results of the Whitehall Study. BMJ. 1986;293:306-308.
37. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
38. Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British doctors. BMJ. 1976;2:1525-1536.
39. Hammond EC. Smoking in relation to death rates of one million men and women. In: Haenszel W, ed. Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. Bethesda, Md: US Dept of Health, Education, and Welfare; 1966:127-204.
40. Marmot MG, Shipley MJ, Rose G. Inequalities in death: specific explanations of a general pattern? Lancet. 1984;1:1003-1006.
41. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed for up to five years. Am Heart J. 1984;108:759-769.
42. Iso H, Jacobs DR, Wentworth D, Neaton J, Cohen J. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989; 320:904-910.
43. Strachan DP. Ventilatory function as a predictor of fatal stoke. BMJ. 1991;302:84-87.
44. Schatzkin A, Hoover RN, Taylor PR, et al. Site-specific analysis of total serum cholesterol and incident cancer in the NHANES I Epidemiologic Follow-up Study. Cancer Res. 1988;48:452-458.
45. Keys A, Aravanis C, Blackburn H, et al. Serum cholesterol and cancer mortality in the Seven Countries Study. Am J Epidemiol. 1985;121:870-883.
46. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol. 1988;41:519-530.
47. Thomas CB, Duszynski KR, Shaffer JW. Cholesterol levels in young adulthood and subsequent cancer: a preliminary note. Johns Hopkins Med J. 1982;150:89-94.
48. Vitols S, Gahrton G, Bjorkholm M, Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density lipoprotein receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet. 1985;2:1150-1154.
49. Budd D, Ginsberg H. Hypocholesterolaemia and acute myelogenous leukaemia. Cancer. 1986;58:1361-1365.
50. Rose G, Blackburn H, Keys A, et al. Colon cancer and blood-cholesterol. Lancet. 1974;1:181-183.
51. Tornberg SA, Holm L-E, Carstensen JM, Eklund GA, Odont D. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med. 1986;315:1629-1633.
52. Stemmermann GN, Nomura AMY, Heilbrun LK, Pollack ES, Kagan A. Serum cholesterol concentration and colon cancer incidence in Hawaiian Japanese men. J Natl Cancer Inst. 1981;67:1179-1182.
53. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in populations with low cholesterol concentrations. BMJ. 1991;303:276-282.
54. Neugut AI, Fink DJ, Radin D. Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol. 1989;4:798-801.
55. Abramson ZH, Kark JD. Serum cholesterol and primary brain tumours: a case-control study. Br J Cancer. 1985;52:93-98.
56. Basu TK, Raven RW, Dickerson JWT, Williams DC. Vitamin A nutrition and its relationship with plasma cholesterol level in the patients with cancer. Int J Vitam Nutr Res. 1974;44:14-18.
57. Knekt P, Reunanen A, Teppo L. Serum cholesterol concentrations and risk of primary brain tumours. BMJ. 1991;302:90.
58. Davey Smith G, Neaton J, Ben-Shlomo Y, Shipley MJ, Wentworth D. A prospective study of serum cholesterol concentration and primary brain tumours. Am J Epidemiol. In press.
59. Pekkanen J, Nissinen A, Punsar S, Karvonen MJ. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up: the Finnish cohorts of the Seven Countries Study. Arch Intern Med. 1989;149:1589-1591.
60. Phillips A, Davey Smith G. How independent are ‘independent’ effects? relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44:1223-1231.
61. Davey Smith G, Phillips AN. Declaring independence: why we should be cautious. J Epidemiol Community Health. 1990;44:257-258.
62. Kerttula Y, Weber T. Serum lipids in pneumonia of different aetiology. Ann Clin Res. 1988;20:184-188.
63. Fiser RH, Denniston JC, Beisel WR. Infection with Diplococcus pneumonia and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J Infect Dis. 1972;125:54-60.
64. Fox AJ, Collier PF. Low mortality rates in industrial cohort studies due to selection for work and survival in the industry. Br J Prev Soc Med. 1976;30:225-230.
65. Johansen H, Semenciw R, Morrison H, et al. Important risk factors for death in adults: a 10-year follow-up of the Nutrition Canada Survey cohort. Can Med Assoc J. 1987;136:823-828.
66. Dagenais G, Ahmed Z, Robitaille NM, et al. Total and coronary heart disease mortality in relation to major risk factors: Quebec Cardiovascular Study. Can J Cardiol. 1990;6:59-65.
67. Goldbourt U, Yaari S. Cholesterol and coronary heart disease mortality: a 23-year follow-up study of 9902 men in Israel. Arteriosclerosis. 1990;10:512-519.
68. Johansson BW, Persson B. Coronary heart disease in Malmo: incidence and long-term follow-up of the Kockum Study. In: Skandia International Symposia, ed. Early Phases of Coronary Heart Disease: The Possibility of Prediction. Stockholm, Sweden: Nordiska Bokhandelns Forlag; 1973:314-322.
69. Petersson B, Trell E, Hood B. Premature death and associated risk factors in urban middle-aged men. Am J Med. 1984;77:418-426.
70. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years follow-up from the Framing-ham Study. JAMA. 1987;257:2176-2180.
71. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol-lowering drugs? BMJ. In press.
72. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990;301:309-314.